Related references
Note: Only part of the references are listed.Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia
A. L. Guillozet-Bongaarts et al.
MOLECULAR PSYCHIATRY (2014)
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish
Daniela Braida et al.
PSYCHOPHARMACOLOGY (2014)
The Novel α7β2-Nicotinic Acetylcholine Receptor Subtype Is Expressed in Mouse and Human Basal Forebrain: Biochemical and Pharmacological Characterization
Milena Moretti et al.
MOLECULAR PHARMACOLOGY (2014)
Nicotinic acetylcholine receptors controlling attention: Behavior, circuits and sensitivity to disruption by nicotine
Rogier B. Poorthuis et al.
BIOCHEMICAL PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: LIGAND-GATED ION CHANNELS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: TRANSPORTERS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ENZYMES
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Motor and Anxiety Effects of PNU-282987, An Alpha7 Nicotinic Receptor Agonist, and Stress in an Animal Model of Alzheimer's Disease
Paloma Vicens et al.
CURRENT ALZHEIMER RESEARCH (2013)
ChAT-ChR2-EYFP Mice Have Enhanced Motor Endurance But Show Deficits in Attention and Several Additional Cognitive Domains
Benjamin Kolisnyk et al.
JOURNAL OF NEUROSCIENCE (2013)
Forebrain Deletion of the Vesicular Acetylcholine Transporter Results in Deficits in Executive Function, Metabolic, and RNA Splicing Abnormalities in the Prefrontal Cortex
Benjamin Kolisnyk et al.
JOURNAL OF NEUROSCIENCE (2013)
Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease
H. Rheinallt Parri et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease
Tanya L. Wallace et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice
J. W. Young et al.
GENES BRAIN AND BEHAVIOR (2011)
Impaired Attention in the 3xTgAD Mouse Model of Alzheimer's Disease: Rescue by Donepezil (Aricept)
Carola Romberg et al.
JOURNAL OF NEUROSCIENCE (2011)
RG3487, a Novel Nicotinic alpha 7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents
Tanya L. Wallace et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Novel Strains of Mice Deficient for the Vesicular Acetylcholine Transporter: Insights on Transcriptional Regulation and Control of Locomotor Behavior
Cristina Martins-Silva et al.
PLOS ONE (2011)
Selective nicotinic receptor antagonists: effects on attention and nicotine-induced attentional enhancement
Britta Hahn et al.
PSYCHOPHARMACOLOGY (2011)
Nicotinic Acetylcholine Receptor β2 Subunits in the Medial Prefrontal Cortex Control Attention
Karine Guillem et al.
SCIENCE (2011)
Elimination of the Vesicular Acetylcholine Transporter in the Striatum Reveals Regulation of Behaviour by Cholinergic-Glutamatergic Co-Transmission
Monica S. Guzman et al.
PLOS BIOLOGY (2011)
Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia
Peixiong Yuan et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Prefrontal β2 Subunit-Containing and α7 Nicotinic Acetylcholine Receptors Differentially Control Glutamatergic and Cholinergic Signaling
Vinay Parikh et al.
JOURNAL OF NEUROSCIENCE (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
R3487/MEM 3454, a novel nicotinic alpha 7 receptor partial agonist, improves attention and working memory performance in cynomolgus macaques
T. L. Wallace et al.
BIOCHEMICAL PHARMACOLOGY (2009)
A Novel Nicotinic Acetylcholine Receptor Subtype in Basal Forebrain Cholinergic Neurons with High Sensitivity to Amyloid Peptides
Qiang Liu et al.
JOURNAL OF NEUROSCIENCE (2009)
SPATIAL AND INTRACELLULAR RELATIONSHIPS BETWEEN THE α7 NICOTINIC ACETYLCHOLINE RECEPTOR AND THE VESICULAR ACETYLCHOLINE TRANSPORTER IN THE PREFRONTAL CORTEX OF RAT AND MOUSE
A. M. Duffy et al.
NEUROSCIENCE (2009)
Effect of R3487/MEM3454, a novel nicotinic α7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats
Amir H. Rezvani et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the α7 nicotinic acetylcholine receptor:: In vitro and in vivo activity
Brad A. Acker et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Genotype effects of CHRNA7, CNRI and COMT in schizophrenia:: interactions with tobacco and cannabis use
Stanley Zammit et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to men
Ann Olincy et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Prefrontal acetylcholine release controls cue detection on multiple timescales
Vinay Parikh et al.
NEURON (2007)
Broad-spectrum efficacy across cognitive domains by α7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways
Robert S. Bitner et al.
JOURNAL OF NEUROSCIENCE (2007)
Postnatal upregulation of α4 and α3 nicotinic receptor subunits in the brain of α7 nicotinic receptor-deficient mice
W.-F. Yu et al.
NEUROSCIENCE (2007)
Top-down versus bottom-up control of attention in the prefrontal and posterior parietal cortices
Timothy J. Buschman et al.
SCIENCE (2007)
The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task
Svetlana Semenova et al.
NEUROPHARMACOLOGY (2007)
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice
Jared W. Young et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
SSR180711, a novel selective alpha 7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia
Philippe Pichat et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task
E. Hoyle et al.
PSYCHOPHARMACOLOGY (2006)
Proof-of-concept trial of an α7 nicotinic agonist in schizophrenia
Ann Olincy et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
α7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal UP induction in β-amyloid infused rats
L Chen et al.
NEUROPHARMACOLOGY (2006)
Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice
H Kamei et al.
BIOLOGICAL PSYCHIATRY (2006)
The selective α7 nicotinic acetylcholine receptor agonist PNU-282987[N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats
M Hajós et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Performance of the marmoset monkey on computerized tasks of attention and working memory
S Spinelli et al.
COGNITIVE BRAIN RESEARCH (2004)
Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate
RL Buckner
NEURON (2004)
Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38
XH Lu et al.
BRAIN RESEARCH (2004)
Protein kinase C overactivity impairs prefrontal cortical regulation of working memory
SG Birnbaum et al.
SCIENCE (2004)
Nicotine improves sustained attention in mice:: Evidence for involvement of the α7 nicotinic acetylcholine receptor
JW Young et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Nicotine as a modulator of behavior: beyond the inverted U
MR Picciotto
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Attentional effects of nicotinic agonists in rats
B Hahn et al.
NEUROPHARMACOLOGY (2003)
Reversal of a vigilance decrement in the aged rat by subtype-selective nicotinic ligands
AJ Grottick et al.
NEUROPSYCHOPHARMACOLOGY (2003)
CO-expression of alpha 7 and beta 2 nicotinic acetylcholine receptor subunit mRNAS within rat brain cholinergic neurons
L Azam et al.
NEUROSCIENCE (2003)
Executive functions and their disorders
R Elliott
BRITISH MEDICAL BULLETIN (2003)
Cognitive mechanisms of nicotine on visual attention
NS Lawrence et al.
NEURON (2002)
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
TW Robbins
PSYCHOPHARMACOLOGY (2002)
Control of goal-directed and stimulus-driven attention in the brain
M Corbetta et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families
JZ Xu et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2001)
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum
FM Zhou et al.
NATURE NEUROSCIENCE (2001)
Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release
PJ Kenny et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task
AJ Grottick et al.
BEHAVIOURAL BRAIN RESEARCH (2000)
(-)-spiro[1-azabicyclo[2.2.2]octane-3,5′-oxazolidin-2′-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the α7 nicotinic acetylcholine receptor
G Mullen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex
K Mirnics et al.
NEURON (2000)
Amyloid peptide A beta(1-42) binds selectively and with picomolar affinity to alpha 7 nicotinic acetylcholine receptors
HY Wang et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
